Your browser doesn't support javascript.
loading
Morphine upregulates Toll-like receptor 4 expression and promotes melanomas in mice.
Vaseghi, Golnaz; Ghasemi, Ahmad; Laher, Ismail; Alaei, HojjatAllah; Dana, Nasim; Naji Esfahani, Hajar; Javanmard, Shaghayegh Haghjooy.
Afiliação
  • Vaseghi G; Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Ghasemi A; Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Laher I; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Alaei H; Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Dana N; Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Naji Esfahani H; Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Javanmard SH; Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Immunopharmacol Immunotoxicol ; 45(3): 347-354, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36382834

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Receptor 4 Toll-Like / Morfina Tipo de estudo: Guideline / Prognostic_studies Limite: Animals Idioma: En Revista: Immunopharmacol Immunotoxicol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Receptor 4 Toll-Like / Morfina Tipo de estudo: Guideline / Prognostic_studies Limite: Animals Idioma: En Revista: Immunopharmacol Immunotoxicol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã